DiMartino Jorge 4
4 · Kronos Bio, Inc. · Filed Dec 13, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
DiMartino Jorge
Chief Medical Officer & VP
Transactions
- Sale
Common Stock
2023-12-12$1.30/sh−17,367$22,664→ 327,255 total
Footnotes (2)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $1.305, and the range of prices were between $1.215 to $1.41. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.